|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.06 SEK | -.--% |
|
-.--% | +3.45% |
| 31/05 | Peptonic Medical Secures European Patent for Treatment of Vulvodynia | MT |
| 31/05 | Peptonic Medical AB Grants Patent in Europe for Relief of Provoked Vulvodynia in Women, Product Ready for Launch | CI |
Peptonic CEO Erik Sundquist presented the company on Biostock Life Summit Event in Lund October 26, 2023. If you were unable to see the event live please see the Peptonic presentation here.
Attachments
Disclaimer
PEPTONIC Medical AB published this content on 31 October 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 31 October 2023 10:35:49 UTC.
| 1st Jan change | Capi. | |
|---|---|---|
| +3.45% | 88.56L | |
| +19.33% | 12TCr | |
| +13.95% | 11TCr | |
| -3.53% | 2.47TCr | |
| +2.71% | 2.27TCr | |
| -9.95% | 1.81TCr | |
| -41.48% | 1.67TCr | |
| -12.62% | 1.66TCr | |
| +0.99% | 1.35TCr | |
| +21.79% | 1.13TCr |
PEPTONIC MEDICAL AB 
